CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)
US:NASDAQ Investor Relations:
collplant.com/investor-relation
Company Research
Source: Yahoo! Finance
Q4 2024 Cost of Revenue: $272,000, down from $773,000 in Q4 2023. Full Year 2024 Cost of Revenue: $1.6 million, down from $2 million in 2023. Q4 2024 Gross Loss: $108,000, compared to $474,000 in Q4 2023. Full Year 2024 Gross Loss: $1.1 million, compared to a gross profit of $9 million in 2023. Q4 2024 Operating Expenses: $3.9 million, down from $4.6 million in Q4 2023. Full Year 2024 Operating Expenses: $16.1 million, down from $16.5 million in 2023. Q4 2024 Net Loss: $3.9 million or $0.34 per share, compared to $4.7 million or $0.41 per share in Q4 2023. Full Year 2024 Net Loss: $16.6 million or $1.45 per share, compared to $7 million or $0.62 per share in 2023. Cash and Cash Equivalents (Dec 31, 2024): $11.9 million. Cash Used in Operating Activities (2024): $14.1 million, compared to $2.8 million in 2023. Cash Used in Investing Activities (2024): $539,000, compared to $1.2 million provided in 2023. Cash Provided by Financing Activities (2024): $9,000, compar
Show less
Read more
Impact Snapshot
Event Time:
CLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLGN alerts
High impacting CollPlant Biotechnologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLGN
News
- CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.MarketBeat
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]Yahoo! Finance
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR Newswire
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTSPR Newswire
- CollPlant Expands its rhCollagen Distribution Capabilities in the United States and CanadaPR Newswire
CLGN
Earnings
- 11/26/25 - Miss
CLGN
Sec Filings
- 11/28/25 - Form SCHEDULE
- 11/26/25 - Form 6-K
- 11/26/25 - Form 6-K
- CLGN's page on the SEC website